<> Patients not in septic shock may or may not receive their first dose of antibiotic over 30 minutes and may have prolonged infusion started immediately. We aimed to determine whether a 3-h extended infusion (EI) of meropenem achieves fT > MIC > 40 on the first and third days of therapy in patients with … 1025 0 obj <>stream pseudomonas) How: 1. * Extended infusion not applicable to NICU patients. endobj Standard aseptic techniques should be used for solution preparation and administration. 2 0 obj In Summary. Extended Infusion Cefepime and Meropenem Tip Sheet What: Cefepime orders are defaulting to 4 hour infusions; Meropenem will default to 3 hours. %%EOF Traditionally, meropenem has been dosed 1 g IV q 8 hrs for serious infections. * IV push available, however, prolonged infusion is the preferred method of administration ** 30-60 minute infusion on Freedom 60 pump, no IV push available *** 60-90 minute infusion on Freedom 60 pump, no IV push available Factors that prohibit short infusions or IV push antibiotics with OPAT may include (but are not limited to): áCX©æ °X[H1„ UØêÌÁÑÑ`ÑÁÜàÚÁ–ÑÐÐÑæ2i4¤u°x ¹@A—ˆˆDˆ Interview By: Timothy P. Gauthier, Pharm.D., BCPS-AQ ID [Last … Optimal anti-bacterial activity of meropenem requires maintenance of its plasma concentration (Cp) above the minimum inhibitory concentration (MIC) of the pathogen for at least 40% of the dosing interval (fT > MIC > 40). • The medicine must be injected slowly, so the needle will need to stay in place for at least 15 to 30 minutes. Meropenem by CI was diluted in 100 mL of 0.9% saline solution and injected into a central venous catheter via a volumetric pump (Braum Mesulgen, Mesulgen, Germany) with an infusion dead space of < 2 mL. Methods: An open-label randomized controlled clinical trial was conducted. Proper use of meropenem A nurse or other trained health professional will give you or your child meropenem. If the YCD 95% minimum content limit is applied, the infusion period must be reduced to less than 6 hours for body-worn devices, especially at the higher concentration studied (25 mg/mL). The protocol consists of a model previously performed in other tissues . For carbape… Solution #2: Meropenem 100mg/50mL 0.9%NaCl for a concentration of 2mg/mL. Meropenem for injection (I.V.) Doses of 1 gram may also be administered as an intravenous bolus injection (5 mL to 20 mL) over approximately 3 minutes to 5 minutes . For other pediatric patients less than 1 year of age the pharmacist must discuss the dose adjustment with the medical team who initiated the order. 63 Therefore, continuous infusion of meropenem 3 g/day could be divided into six … 2.2. Cefiderocol was non-inferior to high-dose, extended-infusion meropenem in terms of all-cause mortality on day 14 in patients with Gram-negative nosocomial pneumonia, with similar tolerability. Study Protocol. When treating complicated skin and skin structure infections caused by P. aeruginosa, a dose of 1 gram every 8 hours is recommended.Meropenem for injection (I.V.) %PDF-1.5 Further dilute in 50 mL or 250 mL of 0.9% Sodium Chloride Injection and administer over 8 hours. Preparation of Solution: 3 g/day continuous IV infusion: Reconstitute a 1 g vial according to manufacturer recommendations. endobj stream 1020 0 obj <>/Filter/FlateDecode/ID[<0C419DF5543B644C9AD9BAE2C3837EA8>]/Index[1014 12]/Info 1013 0 R/Length 51/Prev 459991/Root 1015 0 R/Size 1026/Type/XRef/W[1 2 1]>>stream 62 The 40 mg/mL solution of meropenem reconstituted in isotonic saline was stable at 25°C for a maximum of 8 hours. Blood samples were drawn from a peripheral vein at the end of the infusion (T1), one hour later (T2), and two hours later (T3). **Adjust doses for renal function based on TNMC renal adjustment protocol and infuse over 4 hours. The use of extended infusion beta-lactam dosing strategies is becoming more common and its relevance to clinical practice more relevant in the setting of a limited antibiotic development pipeline. Objective To evaluate current … protocol does NOT include patients in the neonatal intensive care unit. x��][��6�~7�� `1@� �IQ�` ng��3�ij�E2�n������v��Q���CRR/�J�����������#���C���?����kn����˷��\�����|��=��a�����ï�k�����Wɋ�W�?�?����O���˚'������c�{������.�̒:�������4���")�"-���h��er��K��J����g�`�B$oo~���m������Ͼ������#�ez�&ȟ6�n�o�m/X��n�����?n/���a[n:��y���^ԛ������. hÞb```¢ ÉÆ Ā BÌ,@ȱ˜A€ƒA„9x‚à„e‘Œ¼˜X3È7d3Ë0\`è?´hómnÎ@± F†X» Üg˜Ä:ÂÌÝv;¿ìöÛm„[[%[‚%\ ¬á Adjust meropenem 1g IV q8hr to 500mg IV q6hr 2. One gram of meropenem was administered by intravenous infusion for 30 min. (UW Health Weak/Conditional Recommendation, of antibiotic as a 30-minute infusion to reduce the time to a therapeutic concentration. Tazocin® and Meropenem are beta-lactam antibiotics, whose efficacy is dependent upon time above minimum inhibitory concentration (MIC) in affected tissues. Here, several thought-leaders in the field (Dr. Grupper, Dr. Kuti and Dr. Nicolau) weigh in on the topic. hÞbbd``b`Ö õ@‚Q Ä5±Ê€ÄwLŒÌ­ YF$âÿ¿ ñì Continuous IV Infusion: NOTE: Meropenem has not been FDA-approved for administration as a continuous intravenous infusion. Label as solution #1. hÞÔSÛnÛ0ýý@GJ¾)@a ɚm@7M±ò 9‚#À•[)²¿)9Ù²§½ÖmŠ"uŽäC‰J For intravenous infusion, meropenem vials may be directly constituted with 0.9 % sodium chloride or 5% glucose solutions for infusion. Conclusions Meropenem at concentrations between 6.25 mg/mL and 25 mg/mL as tested is not sufficiently stable to administer as a 24-hour infusion in ambulatory device reservoirs. infusion with a pump Loading dose 5mg/kg over at least 20 minutes then continuous infusion of 500 micrograms/kg/hour Usually diluted 500mg in 250 to 500mls (1-2mg/ml) in NS or G. May use undiluted (25mg/ml) via central line at rate not exceeding 25mg/minute. <> In the EI group, 18/76 patients (23.7%) received some of the meropenem doses for less than the 4–hour infusion time due to technical reasons; the mean infusion time per dose during the first 2 days of treatment was 3.62 hours (standard deviation, 0.41 hours) in the EI group. endobj However, the clinical outcomes between two groups remain inconclusive. 100 HAP patients, admitted to ICU of Qilu Hospital of Shandong University, … 4 0 obj Microbiologic success is dependent on pharmacokinetic and pharmacodynamic parameters and the organism’s MIC.8 As previously mentioned, the pharmacodynamic target for beta-lactam antibiotics is the time the drug concentration remains above the MIC of the infecting organism. Remove 2mL from Solution #2. Doses of 1 gram may also be a… 3v2QåÑɅÖZÜßÃ|l¬b†ÌßڍۇƒÈs Ksül]{¢R>ڔv§$ª3í(2«Þ‡Å¢?oïʲˆk„ƒÈ»¸øͼZ˜ÎtqºIæˆð%˜Î5sßvV. The results suggest that cefiderocol is a potential option for the treatment of patients with nosocomial pneumonia, including those caused by multidrug-resistant Gram-negative bacteria. Place in a 100mL bag of 0.9%NaCl to create a Meropenem concentration of 4mg/100mL (0.04mg/mL). It is given through a needle placed into one of your veins. Renal Dosing Adjustment for Pediatric Patients all ages <40kg: • CrCl > 40ml/min = no adjustment Study Protocol. Infusion . However, application of the PK/PD properties of meropenem to create alternative dosing strategies results in equivalent or even greater clinical success. Meropenem to be used for bolus intravenous injection should be reconstituted with sterile water for injection. should be administered by intravenous infusion over approximately 15 minutes to 30 minutes. The 5 mg/mL aqueous reconstituted solution of meropenem was stable for up to 8 hours in the temperature range between 25°C and 35°C, and for up to 5 hours at 40°C. More frequent administration of a beta-lactam typically increases this amount of time. e Ÿ£ƒBÿ CȑõË5 ÍĜ  cTbàrC˜0ˆÆ>q0¿tŽ= ˜nl'AZ¸Œ@ZX€T;÷O0—á'@€ Þ``c b. Why: • PD target for β-lactams: fT>MIC (time above MIC) • Maximize the time-dependent bactericidal activity • Target pathogens with high MIC (e.g. For example, a prolonged infusion of high-dose meropenem (2 g q8h, with each dose infused over 3 h) achieves a high likelihood of obtaining a 40% ƒT>MIC against bacteria with MICs of ≤16 μg/ml. 1014 0 obj <> endobj endstream endobj startxref The protocol consists of a model previously performed in other tissues . In this retrospective study, we compared intensive care unit (ICU) mortality and clinical response in patients who received meropenem for ≥72 hours administered per EIM protocol of 1 g over 3 hours every 8 hours versus intermittent infusion (IIM) protocol of 500 mg over 30 minutes every 6 hours. Infusion. %PDF-1.5 %âãÏÓ Meropenem (Meronem ®, AstraZeneca Pharmaceuticals, Belgium) was administered as either II (infusion over 0.5 h) in 30 patients (II group) or EI (infusion over 3 h) in 25 patients (EI group), at a dose of 1 g every 8 h, which is usually recommended in nosocomial pneumonia. Meropenem was subsequently assayed using high-performance liquid chromatography (HPLC). 0 The method was developed and validated in compliance with International Council for Harmonisation (ICH) guidelines. Extended-Infusion Meropenem (Merrem®) Protocol Related Documents: Patient Care Manual Guide: Medication Administration IV Infusion Guidelines I. For intravenous infusion, meropenem vials may be directly reconstituted with 0.9 % sodium chloride or 5% glucose solutions for infusion. should be administered by intravenous infusion over approximately 15 minutes to 30 minutes. The recommended dose of Meropenem for injection (I.V.) Background Meropenem exhibits time-dependent antimicrobial activity and prolonged infusion (PI) (extended infusion or continuous infusion, EI or CI) of meropenem can better achieve pharmacodynamics target when comparing with intermittent bolus (IB). 3 0 obj Hence, administering these antibiotics by continuous infusion should improve the outcomes of … The solution should be shaken before use . Alaris pumps are programmed to deliver 4-hr infusions for cefepime and piperacillin/tazobactam in all critical care units. Theoretically, therefore, this meropenem regimen should kill KPC-producing bacteria with MICs of 16 μg/ml or less. Meropenem’s stability was examined at two temperatures 22°C and 33°C to mimic average and high temperature in hospital wards. endstream endobj 1015 0 obj <>/Metadata 80 0 R/Pages 1012 0 R/StructTreeRoot 110 0 R/Type/Catalog>> endobj 1016 0 obj <>/MediaBox[0 0 720 540]/Parent 1012 0 R/Resources<>/Pattern<>/ProcSet[/PDF/Text/ImageB/ImageC/ImageI]>>/Rotate 0/StructParents 0/Tabs/S/Type/Page>> endobj 1017 0 obj <>stream
2020 meropenem infusion protocol